Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Chronic treatment with either dexfenfluramine or sibutramine in diet-switched diet-induced obese mice.

Bush EN, Shapiro R, Brune ME, Knourek-Segel VE, Droz BA, Fey T, Lin E, Jacobson PB.

Endocrine. 2006 Apr;29(2):375-81.

PMID:
16785615
2.

Amyrins from Protium heptaphyllum Reduce High-Fat Diet-Induced Obesity in Mice via Modulation of Enzymatic, Hormonal And Inflammatory Responses.

Carvalho KM, de Melo TS, de Melo KM, Quinderé AL, de Oliveira FT, Viana AF, Nunes PI, Quetz JD, Viana DA, da Silva AA, Havt A, Fonseca SG, Chaves MH, Rao VS, Santos FA.

Planta Med. 2017 Feb;83(3-04):285-291. doi: 10.1055/s-0042-114222. Epub 2016 Aug 15.

PMID:
27525508
4.

Effects of a novel Y5 antagonist in obese mice: combination with food restriction or sibutramine.

Mashiko S, Ishihara A, Iwaasa H, Moriya R, Kitazawa H, Mitobe Y, Ito J, Gomori A, Matsushita H, Takahashi T, MacNeil DJ, Van der Ploeg LH, Fukami T, Kanatani A.

Obesity (Silver Spring). 2008 Jul;16(7):1510-5. doi: 10.1038/oby.2008.223. Epub 2008 Apr 10.

5.

Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats.

Roth JD, Trevaskis JL, Wilson J, Lei C, Athanacio J, Mack C, Kesty NC, Coffey T, Weyer C, Parkes DG.

Int J Obes (Lond). 2008 Aug;32(8):1201-10. doi: 10.1038/ijo.2008.91. Epub 2008 Jun 17.

PMID:
18560368
6.

Anti-obesity effects of KR-66195, a synthetic DPP-IV inhibitor, in diet-induced obese mice and obese-diabetic ob/ob mice.

Lee EY, Kim YW, Oh H, Choi CS, Ahn JH, Lee BW, Kang ES, Cha BS, Lee HC.

Metabolism. 2014 Jun;63(6):793-9. doi: 10.1016/j.metabol.2014.02.011. Epub 2014 Feb 25.

PMID:
24684824
7.

Effects of oleoyl-estrone with dexfenfluramine, sibutramine or phentermine on overweight rats.

Ferrer-Lorente R, Cabot C, Fernández-López JA, Remesar X, Alemany M.

Eur J Pharmacol. 2005 Apr 25;513(3):243-8. Epub 2005 Apr 14.

PMID:
15862807
8.

Effects of changing dietary fat content on plasma gut hormone concentrations in diet-induced obese and diet-resistant rats.

Li J, Wang S, Zhang N, Li Z, Li R, Li C.

Br J Nutr. 2011 Mar;105(6):879-86. doi: 10.1017/S0007114510004381. Epub 2010 Nov 9.

PMID:
21059280
9.

Soluble Fermentable Dietary Fibre (Pectin) Decreases Caloric Intake, Adiposity and Lipidaemia in High-Fat Diet-Induced Obese Rats.

Adam CL, Thomson LM, Williams PA, Ross AW.

PLoS One. 2015 Oct 8;10(10):e0140392. doi: 10.1371/journal.pone.0140392. eCollection 2015.

10.

Abnormalities of leptin and ghrelin regulation in obesity-prone juvenile rats.

Levin BE, Dunn-Meynell AA, Ricci MR, Cummings DE.

Am J Physiol Endocrinol Metab. 2003 Nov;285(5):E949-57. Epub 2003 Jul 15.

11.

Anorexic effects of intra-VTA leptin are similar in low-fat and high-fat-fed rats but attenuated in a subgroup of high-fat-fed obese rats.

Bruijnzeel AW, Qi X, Corrie LW.

Pharmacol Biochem Behav. 2013 Jan;103(3):573-81. doi: 10.1016/j.pbb.2012.10.012. Epub 2012 Oct 27.

12.

Antiobesity activities of indole-3-carbinol in high-fat-diet-induced obese mice.

Chang HP, Wang ML, Chan MH, Chiu YS, Chen YH.

Nutrition. 2011 Apr;27(4):463-70. doi: 10.1016/j.nut.2010.09.006.

PMID:
21392705
13.

Chronic injection of pansomatostatin agonist ODT8-SST differentially modulates food intake and decreases body weight gain in lean and diet-induced obese rats.

Stengel A, Coskun T, Goebel-Stengel M, Craft LS, Alsina-Fernandez J, Wang L, Rivier J, Taché Y.

Regul Pept. 2011 Apr 11;167(2-3):201-8. doi: 10.1016/j.regpep.2011.01.006. Epub 2011 Feb 17.

14.
15.

Diet-induced obese mice are leptin insufficient after weight reduction.

Shi H, Akunuru S, Bierman JC, Hodge KM, Mitchell MC, Foster MT, Seeley RJ, Reizes O.

Obesity (Silver Spring). 2009 Sep;17(9):1702-9. doi: 10.1038/oby.2009.106. Epub 2009 Apr 16.

16.
17.

Chronic 5-HT6 receptor modulation by E-6837 induces hypophagia and sustained weight loss in diet-induced obese rats.

Fisas A, Codony X, Romero G, Dordal A, Giraldo J, Mercé R, Holenz J, Vrang N, Sørensen RV, Heal D, Buschmann H, Pauwels PJ.

Br J Pharmacol. 2006 Aug;148(7):973-83. Epub 2006 Jun 19. Erratum in: Br J Pharmacol. 2007 Jun;151(4):564. Vrang, N [added]; Sørensen, R V [added].

18.

Effects of liraglutide and sibutramine on food intake, palatability, body weight and glucose tolerance in the gubra DIO-rats.

Hansen G, Jelsing J, Vrang N.

Acta Pharmacol Sin. 2012 Feb;33(2):194-200. doi: 10.1038/aps.2011.168.

19.
20.

Effect of Weight-Reduction in Obese Mice Lacking Toll-Like Receptor 5 and C57BL/6 Mice Fed a Low-Fat Diet.

Wu SC, Rau CS, Lu TH, Tzeng SL, Wu YC, Wu CJ, Lin CW, Hsieh CH.

Mediators Inflamm. 2015;2015:852126. doi: 10.1155/2015/852126. Epub 2015 Nov 23.

Supplemental Content

Support Center